1 Unintended pregnancy and its impact on childhood rotavirus immunization in Peru.

2 Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework.

3 Pharmacists in Federally Qualified Health Centers: Models of Care to Improve Chronic Disease.

4 Pathogen-Specific Impacts of the 2011-2012 La Niña-Associated Floods on Enteric Infections in the MAL-ED Peru Cohort: A Comparative Interrupted Time Series Analysis.

5 Etiologies, Risk Factors and Impact of Severe Diarrhea in the Under-Fives in Moramanga and Antananarivo, Madagascar

6 ocorrência de rota vírus e adeno vírus em crianças de até 11 anos de idade sem sintomatologia de diarréia em goiânia - go

7 cost-effectiveness analysis of rotavirus vaccination among libyan children using a simple economic model

8 leite de mulheres brasileiras apresenta anticorpos iga secretores (siga) que neutralizam o rotavírus g9p[5]

9 rotavirus epidemiology before and after vaccine introduction

10 effect of cell culture system on the production of human viral antigens efeito do sistema de cultura celular na produção de antígenos virais humanos

11 rotavirus infection and the current status of rotavirus vaccines

12 the frequency of rotavirus and enteric adenovirus in children with acute gastroenteritis in mardin

13 infeksi rotavirus pada anak usia di bawah dua tahun

14 the interactions between host glycobiology, bacterial microbiota, and viruses in the gut

15 oral administration of a seed-based bivalent rotavirus vaccine containing vp6 and nsp4 induces specific immune responses in mice

16 molecular characterisation and clinical correlates of rotavirus in children and adults in a tertiary care centre, chennai, south india

17 Área de ciencias básicas y experimentales: determinación de la función de la proteína vp6 y los péptidos (280-297) de vp6 (530-559) de vp4 en la entrada de rotavirus.

18 intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection

19 A Cross-Sectional Study of Socio-Demographic Factors and Vaccination Compliance Among Children Under Two in Bhubaneswar, India, With Emphasis on Parental Education.

20 Further considerations on rotavirus vaccination and seizure-related hospitalization rates

21 Letter to the editor regarding “Rotavirus infection beyond the gut”

22 Rotavirus infection beyond the gut

23 Further considerations on rotavirus vaccination and seizure-related hospitalization rates

24 Letter to the editor regarding “Rotavirus infection beyond the gut”

25 Rotavirus infection beyond the gut

26 Differential and enhanced response to climate forcing in diarrheal disease due to rotavirus across a megacity of the developing world.

27 Coverage and Determinants of Uptake for Privately Funded Rotavirus Vaccine in a Canadian Birth Cohort, 2008-2013.

28 Knowledge, attitudes, beliefs, and behaviors of parents and healthcare providers before and after implementation of a universal rotavirus vaccination program.

29 Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis.

30 Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules

31 Enteropathogens and Rotavirus Vaccine Immunogenicity in a Cluster Randomized Trial of Improved Water, Sanitation and Hygiene in Rural Zimbabwe

32 The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial

33 Longitudinal study of rotavirus C VP6 genotype I6 in diarrheic piglets up to 1 week old.

34 The Impact of Human Genetic Polymorphisms on Rotavirus Susceptibility, Epidemiology, and Vaccine Take.

35 Success of rotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness

36 Impact of the Introduction of Rotavirus Vaccine on Hospital Admissions for Diarrhea Among Children in Kenya: A Controlled Interrupted Time-Series Analysis

37 Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

38 RotaC: A web-based tool for the complete genome classification of group A rotaviruses

39 Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

40 Effectiveness of Monovalent Rotavirus Vaccine Against Hospitalization With Acute Rotavirus Gastroenteritis in Kenyan Children

41 Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

42 Comparison of Premier™ Rotaclone®, ProSpecT™, and RIDASCREEN® rotavirus enzyme immunoassay kits for detection of rotavirus antigen in stool specimens

43 The Pentavalent Rotavirus Vaccine: Discovery to Licensure and Beyond

44 Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient–Level Costing Data

45 RotaC: a web-based tool for the complete genome classification of group A rotaviruses

46 Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting

47 Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

48 Global, Regional, and National Estimates of Rotavirus Mortality in Children

49 Measuring Rotavirus Vaccine Impact in Sub-Saharan Africa

50 Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes

51 The Impact of Improved Water, Sanitation, and Hygiene on Oral Rotavirus Vaccine Immunogenicity in Zimbabwean Infants: Substudy of a Cluster-randomized Trial

52 Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

53 Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children

54 Global seasonality of rotavirus infections

55 Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward

56 Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda

57 Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction

58 Rotavirus vaccines WHO position paper: January 2013 - Recommendations

59 Impact and effectiveness of pentavalent rotavirus vaccine in children

60 Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis

61 Rotavirus vaccine effectiveness in low-income settings: An evaluation of the test-negative design

62 Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study

63 Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study

64 Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses

65 [A systematic review of the risk of oral rotavirus vaccine and intussusception]

66 Impact of Rotavirus Vaccine Introduction and Postintroduction Etiology of Diarrhea Requiring Hospital Admission in Haydom, Tanzania, a Rural African Setting

67 Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies

68 Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh

69 A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

70 Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

71 Rotavirus vaccines:an update

72 Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors

73 Impact of rotavirus vaccination on rotavirus hospitalisation rates among a resource-limited rural population in Mbita, Western Kenya

74 Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

75 Performance of rotavirus vaccines in developed and developing countries

76 A Preliminary Assessment of Rotavirus Vaccine Effectiveness in Zambia

77 Human rotavirus vaccine Rotarix ™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial

78 Update of rotavirus strains circulating in Africa from 2007 through 2011

79 Incidence and Clinical Characteristics of Group A Rotavirus Infections among Children Admitted to Hospital in Kilifi, Kenya

80 High burden of rotavirus gastroenteritis in young children in rural western Kenya, 2010-2011

81 Real-World Effectiveness of Pentavalent Rotavirus Vaccine Among Bedouin and Jewish Children in Southern Israel

82 Global Review of the Age Distribution of Rotavirus Disease in Children Aged

83 Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine

84 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

85 Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination

86 Global, Regional, and National Estimates of Rotavirus Mortality in Children

87 Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study

88 Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward

89 Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection

90 full genome characterization of novel ds-1-like g9p[8] rotavirus strains that have emerged in thailand.

91 construction and analysis of decision-making model in assessing the impact of vaccination with rotavirus vaccine in ukraine

92 un modelo del mecanismo de entrada de los rotavirus a la cÉlula hospedera

93 rotavirus gastroenteritis and a rare case accompanying acute pancreatitis

94 features of cellular immunity in children with mono- and mixed rotavirus infection

95 rotavirus replication and the role of cellular lipid droplets: new therapeutic targets?

96 no direct correlation between rotavirus diarrhea and breast feeding: a meta-analysis

97 abo blood grouping in egyptian children with rotavirus gastroenteritis

98 modern views on rotavirus infection in children: epidemiological and clinicopathogenetic features

99 toxin mediated diarrhea in the 21st century: the pathophysiology of intestinal ion transport in the course of etec, v. cholerae and rotavirus infection

100 impacto de la introducción de la vacuna contra el rotavirus en la hospitalización por gastroenteritis aguda grave en el hospital del niño de la ciudad de panamá impact of rotavirus vaccine introduction on hospital admissions for severe acute gastroenteritis at the children's hospital in panama city

101 prevalence of rotavirus in children hospitalized with acute gastroenteritis in imam sajjad hospital of yasuj, 2011

Keyword Connections

Journals

Research Groups

Bibliographies